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The incidence of cutaneous melanoma has increased exponen-
tially in the last 50 years. In 1935 the lifetime risk of developing 
melanoma was 1: 1500; by the mid- 1980s the risk had increased 
to more than 1: 150. If the increase continues, the estimated 
lifetime risk will be 1:90 in the year 2000. 1 The clinical criteria are: 
Asymmetry, irregular border, color variegation, and a diameter 
greater than 6 mm. 2 This report describes the occurrence of 
melanoma in an active duty troop. The authors wish to stress the 
importance of early detection of cutaneous melanoma and the 
inclusion of melanoma in the differential diagnosis on physical 
examination of young people. 
Case Report 
An 18-year-old active duty soldier presented to the clinic for 
evaluation of a mole on his right upper back that had been 
present for at least 2 years. Information provided at the time of 
his induction physical was remarkable only for "mild acne 
scarring on the back." There was no family history of skin 
cancer, although the patient has a history of multiple sunburning 
episodes. 
He had fair skin, light-colored hair, and blue eyes. There was 
a 1.2 em by 1.5 em brown to black-colored plaque involving the 
right upper back (Fig 1 ). The borders were irregular and the color 
varied throughout the lesion. The plaque was excised with 1 mm 
margins. 
On histologic examination there were atypical nests of epithe-
lioid cells within the epidermis extending into the dermal 
regions to a depth of 2.5 mm. There were numerous mitotic 
figures and abundant melanin within melanophages. The mar-
gins were clear. These features were interpreted as being consis-
tent with the diagnosis of malignant melanoma. 
A chest roentgenogram and chest CT scan were normal. 
Serum lactate dehydrogenase (LDH) levels were also normal. 
Additional surgical margins were taken (3 em diameter from 
original site) and a split-thickness graft performed at the site. 
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Fig 1. -1.2 em by 1.5 em brown to black plaque over right shoulder 
region. 
Discussion 
Active duty military personnel are at an increased risk for 
developing skin cancer from increased ultraviolet exposure. 
Ramani et aP surveyed 370 World War II veterans with skin 
cancer in reference to station location, place of service, skin 
cancer types, skin type, ethnic background, and estimated aver-
age hours outdoors per day during their lifetime. More patients 
with skin cancer were stationed in the Pacific (66%) than in 
Europe (34%) during the war (statistically significant on chi-
square test). The authors conclude: 1) this study links early, 
time-limited, but intense sun exposure with the development of 
cutaneous malignancy years later; 2) persons with heavy sun 
exposure in the South Pacific or in Vietnam should be counseled 
to avoid future sun exposure; and 3) military personnel who 
serve in tropical and subtropical climates should be advised to 
avoid sunburns and use sunscreens regularly. 
In another military study performed by Garland et al4 person-
years at risk and cases of malignant melanoma were determined 
using computerized service records and inpatient hospitaliza-
tion files maintained at the Naval Health Research Center. There 
were a total of 176 confirmed cases of melanoma between 1974 
to 1984. Occupations were categorized into indoor, outdoor, or 
indoor/outdoor groups. Compared to the U.S. civilian popula-
tion, Navy personnel with indoor occupations had a higher age- . 
adjusted incidence rate of melanoma (10.6 per 100,000). Indi-
viduals who worked in occupations requiring both indoor and 
outdoor exposure had the lowest rate (7.0 per 100,000). Two 
single occupations were found to have elevated rates of mela-
noma: Aircrew survival equipmentman and engineman. Inci-
dent rates were found to be higher on the trunk than on more 
HAWAII MEDICAL JOURNAL, VOL. 54 , JULY 1995 
673 
commonly sunlight-exposed areas, such as the head and arms. 
Melanoma is second only to testicular cancer in men serving in 
the U.S. Navy. 
Since cutaneous melanoma is potentially curable by surgical 
excision, early detection and removal of such lesions would 
reduce mortality.5 This can happen only through public and 
professional education programs with particular emphasis on 
targeting high risk individuals. Fair skin, light hair color, freck-
les in adolescence, family members with melanoma, a changing 
mole, or severe sunburns are significant risk factors. 6•7 Since 
military personnel have been shown to be at increased risk for all 
types of skin cancer, thorough cutaneous examination should be 
considered an important part of the physical examination of 
active duty troops regardless of age. Suspicious lesions should 
be biopsied for histologic examination. 
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16 Tips for Better Research Protocol Writing 
Debora Schotik Chan, BS Pharmacy 
U.S. Army medical and pharmacy residents are often re-
quired to perform research. After a research question has 
been identified, many residents find themselves stuck in 
writers' block when trying to write the protocol. Whether the 
research is basic science or clinical in nature, these 16 tips 
will help decrease the amount of time spent idly stuck in 
writers' block or performing rewrites and in turn, will expedite 
the process of Institutional Review Board (IRB) approval. 
1. Be clear and concise. Don't be too wordy. Get rid of any words, 
sentences or phrases you do not need. A protocol that is too wordy will 
be seen as such. 
2. Don't try to impress the IRB with technobabble. A protocol 
filled with technical words used inappropriately will hurt you in the 
long run. IRB members will easily identify this strategy and will 
confront you about it. 
3. Use the format designated by the IRB. The order in which 
information is presented is as important as the content of your 
protocol. Follow the protocol layout recommended by the IRB .If you 
fail to do this, you will be asked to rewrite your protocol. 
4. Follow scientific method. Address introduction, objective, 
hypothesis, design, methods, and data analysis as separate sections in 
the protocol layout. Do the same when writing your completed 
research for publication with the addition of abstract, results, discus-
sion and conclusion sections. These sections will be contained in the 
format designated by the IRB, but will be identified by different 
names. Make sure you use the names recommended by the IRB. 
5. Specify study type and design. Some key study designs are 
prospective, retrospective, single-blind, double-blind, open, ran-
domized, sequential, crossover, placebo, standard control and case 
control. Examples of study types include human use, animal use, 
basic science, and survey. 
6. Write according to the IRB required style. If the IRB does not 
specify a style, use the style recommended by the journal in which you 
plan to publish your manuscript. Most medical journals use Uniform 
Requirements for Manuscripts Submitted to Biomedical Journals 
( JAMA. 1993 ;269:2282-6) andAmerican MedicalAssociationManual 
of Style as standard writing requirements. 
7. Write the introduction last. Start somewhere in the middle. 
Writer's block occurs most often when you try to write a summary 
before you have written the experiment. Start wherever is most 
comfortable for you. Most researchers find that starting at the design 
or methods section is the easiest. 
-
8. Cite results of related studies. IRB members will want to know 
where your study stands in the scientific arena and what contribution 
it will make to the literature. Cite only articles that are relevant to your 
study proposal. 
9. SeD your idea. In response to decreased dollars for research 
funding, the IRB has to cut the number of protocols that are funded. 
Explain why your study will be an important addition to the literature 
or how it will affect hospital policy. If your study will save the hospital 
money, make that point very clear. 
10. Stay within a reasonable budget. Ask for enough money to 
complete the project, but don't overestimate your budget. If your 
study is too expensive or if it is padded with unnecessary costs, it will 
not be funded. Also consider alternative forms of financing for your 
research, such as obtaining grants and collaborating with other 
institutions. 
11. Clarify monetary issues. Don't assume you have the support 
of all departments involved in your project. Many principal investiga-
tors neglect to include funding for medications, supplies, and time 
required from other departments or services in their budgets. Seek 
advice and approval from all departments involved before submitting 
your protocol. 
12. Don't forget ethics. Make sure your study is ethical to all study 
participants. Address any anticipated concerns they may have both in 
the protocol and consent form. A good review of ethical issues is the 
"Belmont Report," Federal Register79-12065 or call U.S. Food and 
Drug Administration, Office of Health Affairs, (301) 443-1382. 
13. Make sure the consent form is written at appropriate 
reading level. All study participants must be able to read and 
understand the form. Make sure the plan, risks and termination 
procedures are clearly explained. Write the form at a Grades 5 to 8 
reading level. 
14. Check spelling and grammar. Run your protocol through both 
the spell and grammar check on your computer. 
15. Read your protocol out loud. The spell check and grammar 
check are not perfect. Words can be spelled correctly but may be used 
incorrectly in that context. This may not be evident until you hear the 
mistake. 
16. Have someone p~:oofread your proposal. Recruit two or more 
people to proofread your protocol if you can. Preferably get someone 
in your field of expertise and someone who does a lot of writing, 
editing, or typing. 
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